The three founders of newly launched Volastra Therapeutics Inc. had plenty in common when they decided to create the company. Their offices happened to be a half block apart on 69th Street in midtown Manhattan. Their interests in oncology were similar but each approached the disease from different angles.
When developmental neurobiologist Arnold Kriegstein talks about his work, it sounds for all the world like he is talking about the brains of teenagers. They are stressed. Their identity is mixed up. But putting them in a good environment is helpful to their development. Kriegstein, though, was describing brain organoids.
The dream in 3D bioprinting is to be able to create a functional organ for human transplantation, but that remains a distant goal. Researchers at Harvard's Wyss Institute for Biologically Inspired Engineering and John Paulson School of Engineering and Applied Sciences (SEAS) have made some steps in the right direction.
